Lucía Núñez Selected Research

Urea (Carbamide)

3/2021

Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lucía Núñez Research Topics

Disease

11	Neoplasms (Cancer) 10/2021 - 09/2004
7	Alzheimer Disease (Alzheimer's Disease) 05/2022 - 07/2008
7	Colonic Neoplasms (Colon Cancer) 01/2019 - 02/2006
5	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 10/2014
3	Heart Failure 01/2018 - 01/2016
2	Cognitive Dysfunction 02/2015 - 07/2008
2	Cardiac Arrhythmias (Arrythmia) 04/2007 - 03/2005
1	Nerve Degeneration 05/2022
1	Tetraploidy 11/2021
1	Heart Diseases (Heart Disease) 03/2021
1	Confusion (Bewilderment) 03/2021
1	Chronic Renal Insufficiency 03/2021
1	Neuroinflammatory Diseases 01/2021
1	Dementia (Dementias) 01/2018
1	Type 2 Diabetes Mellitus (MODY) 04/2017
1	Ulcerative Colitis 01/2017
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2015
1	Adenoma (Adenomas) 01/2015
1	Hypopituitarism (Sheehan's Syndrome) 01/2015
1	Parkinson Disease (Parkinson's Disease) 05/2012
1	Leukemia 05/2011
1	Necrosis 04/2011
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 04/2010
1	Atrial Fibrillation 12/2008
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 08/2008
1	Brugada Syndrome 08/2008
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2007
1	Atherosclerotic Plaque (Atheroma) 04/2007

Drug/Important Bio-Agent (IBA)

7	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019 - 05/2011
5	Amyloid (Amyloid Fibrils)IBA 05/2022 - 01/2012
5	CalciumIBA 06/2017 - 09/2004
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2017 - 01/2016
2	SalicylatesIBA 06/2017 - 02/2006
2	NeurotoxinsIBA 01/2017 - 01/2016
2	Peptides (Polypeptides)IBA 01/2016 - 01/2012
2	Hormones (Hormone)IBA 01/2015 - 09/2004
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2021
1	GalactosidasesIBA 11/2021
1	NocodazoleIBA 11/2021
1	Chimeric Antigen ReceptorsIBA 10/2021
1	Urea (Carbamide)FDA LinkGeneric 03/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Toll-Like Receptor 4IBA 01/2020
1	PolyaminesIBA 01/2019
1	Eflornithine (Ornidyl)FDA Link 01/2019
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2018
1	Messenger RNA (mRNA)IBA 04/2017
1	Anthocyanins (Anthocyanin)IBA 04/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 04/2017
1	Interleukin-33IBA 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017
1	IvabradineIBA 01/2016
1	Growth Hormone (Somatotropin)IBA 01/2015
1	Pituitary Hormone-Releasing HormonesIBA 01/2015
1	Stromal Interaction Molecule 2IBA 10/2014
1	Transient Receptor Potential ChannelsIBA 10/2014
1	Phosphotransferases (Kinase)IBA 05/2012
1	BuffersIBA 05/2011
1	Lipid Bilayers (Lipid Bilayer)IBA 04/2011
1	elisidepsinIBA 04/2011
1	Carrier Proteins (Binding Protein)IBA 04/2010
1	Myosins (Myosin)IBA 04/2010
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2008
1	Calcium Channels (Calcium Channel)IBA 08/2008
1	SodiumIBA 08/2008
1	amyloid beta-protein (1-42)IBA 07/2008
1	Amyloid beta-PeptidesIBA 07/2008
1	AequorinIBA 07/2008
1	AntioxidantsIBA 04/2007
1	oxidized low density lipoproteinIBA 04/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2007
1	Irbesartan FDA LinkGeneric 03/2005
1	Spironolactone (Aldactone)FDA LinkGeneric 03/2005
1	candesartanIBA 03/2005
1	Canrenoic Acid (Potassium Canrenoate)IBA 03/2005
1	Angiotensin IIIBA 03/2005
1	Losartan (Cozaar)FDA LinkGeneric 03/2005
1	Mineralocorticoid Receptor AntagonistsIBA 03/2005
1	eprosartan (Teveten)FDA Link 03/2005
1	Pituitary Hormone-Regulating Hormone ReceptorsIBA 09/2004

Therapy/Procedure

3	Chemoprevention 01/2019 - 01/2016
2	Heart Transplantation (Grafting, Heart) 01/2018 - 01/2018
1	Immunotherapy 10/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2021
1	Therapeutics 04/2017
1	Patient Readmission 01/2016